Pre-analytic variability in cardiovascular biomarker testing
- PMID: 26623116
- PMCID: PMC4635305
- DOI: 10.3978/j.issn.2072-1439.2015.10.03
Pre-analytic variability in cardiovascular biomarker testing
Abstract
The impact of laboratory medicine on clinical cardiology has dramatically increased over the years and a lot of cardiovascular biomarkers have been recently proposed. In order to avoid clinical mistakes, physicians should be well aware of all the aspects, which could affect the quality of laboratory results, remembering that pre-analytic variability is an often overlooked significant source of bias, determining the vast majority of laboratory errors. This review addresses the determinants of pre-analitycal variability in cardiovascular biomarker testing, focusing on the most widespread biomarkers, which are cardiac troponins and natriuretic peptides.
Keywords: Laboratory variability; biomarker; cardiology.
Conflict of interest statement
References
-
- Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin Chem Lab Med 2003;41:871-83. - PubMed
-
- Clerico A, Passino C, Franzini M, et al. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clin Chim Acta 2015;443:17-24. - PubMed
-
- Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67. - PubMed
-
- Jarolim P. High sensitivity cardiac troponin assays in the clinical laboratories. Clin Chem Lab Med 2015;53:635-52. - PubMed
-
- Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054. - PubMed
Publication types
LinkOut - more resources
Full Text Sources